Bone Miner News Today

MONTREAL, Feb. 06, 2024 -- Knight Therapeutics Inc., , a Pan-American specialty pharmaceutical company, announced today the launch of BIJUVA® capsules in Canada. BIJUVA® is indicated for the...

BUCHAREST, Romania, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, today announced it has entered into an exclusive distribution agreement

Er-Kim is appointed as the exclusive Ascendis A/S endocrinology distributor across Central & Eastern Europe and Turkey...

Agreement between Ascendis Pharma A/S and ST is for the exclusive distribution and commercialisation of three Ascendis Pharma endocrinology therapiesTwo of the therapies are already internationally...

/PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) has added three new endocrinology therapies to its specialist...

Real World Evidence Study Showed use of Prolia Reduced Fracture Risk in Postmenopausal Women With Osteoporosis Versus Alendronate Treatment Longer Duration of Treatment With Prolia Was Associated... | May 8, 2023

Ipsen receives new FDA PDUFA date for investigational palovarotene for the treatment of people with FOP PDUFA date has been set for 16 August 2023 following the New Drug Application

Investegate announcements from Ipsen Pharma, Ipsen receives new FDA PDUFA date for investigational palovarotene for the treatment of people with FOP

Company to host radiologist peer-to-peer workshops on TBS Osteo software used to monitor bone health Medimaps Group, a Swiss/Global med-tech company specializing in image-processing software for assessing

Edith Hessel, experienced R&D and biopharma executive, named as Chief Scientific Officer Osteoporosis announced as first indication, driven by Relation's proprietary engine for indication